According to Penn State News, research scientists at Penn State and the University of Michigan discovered a new way to potentially fight against Vancomycin-resistant Enterococci (VRE). Taking an antibiotic in conjunction with an inexpensive, FDA-approved cholesterol drug–cholestyramine–prevents the antibiotic from driving antimicrobial resistance in the gut. Such a therapy is called “anti-antibiotic”.